|
|
When a drug whose mode of action is not clear is confronted by ADME/Tox problem, it is difficult to find a breakthrough since binding target is not clear. That is why target oriented drug discovery is considered a rational approach and many drug discovery companies are adopting this method. However, not all candidates¡¯ targets are determined. CGK provides Target Identification program to pharmaceutical companies or drug development companies with candidates whose targets are not clear.
|